Actively Recruiting
A Study on the Improvement of Postoperative Symptoms and Survival Benefits of Modified Bufei Decoction in Elderly Patients With Lung Cancer Undergoing Radical Surgery
Led by Peking University Cancer Hospital & Institute · Updated on 2026-01-27
174
Participants Needed
2
Research Sites
128 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This is a randomized double-blind placebo-controlled phase II clinical study that included patients with symptoms such as cough, shortness of breath, and fatigue after lung cancer resection surgery. They were given orally modified Bufei Tang granules twice a day for 28 days, with one packet taken orally with water. Using the MDASI-TCM symptom scoring system, evaluate the scores of symptoms such as cough, shortness of breath, and fatigue before and after the experiment, and calculate the difference in scores between the control group and the experimental group before and after the experiment.
CONDITIONS
Official Title
A Study on the Improvement of Postoperative Symptoms and Survival Benefits of Modified Bufei Decoction in Elderly Patients With Lung Cancer Undergoing Radical Surgery
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients with postoperative lung cancer confirmed by clear histological or cytological diagnosis
- Age 65 years or older, any gender
- MDASI-TCM symptom score of 4 or higher for cough, fatigue, or shortness of breath, or a combined score of 6 or higher
- Basically normal heart function; liver enzymes (ALT/AST) within twice the normal value; serum creatinine within normal range
- Traditional Chinese medicine diagnosis of deficiency in both lungs and kidneys
You will not qualify if you...
- Severe lung infections
- Mental illness
- Depression
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 2 locations
1
Beijing cancer hospital
Beijing, Beijing Municipality, China, 100142
Actively Recruiting
2
Beijing cancer hospital
Beijing, Beijing Municipality, China, 100142
Actively Recruiting
Research Team
X
Xu yi chen, MD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
QUADRUPLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here